Catherine Sautès‐Fridman

47.1k citations

251 papers · 27.8k indexed · 15 hit papers · h-index 79

Immunology top 0.02%
Oncology top 0.05%
Molecular Biology top 0.5%
Pulmonary and Respiratory Medicine top 0.2%
Cancer Research top 0.2%

Co-authors: Wolf H. Fridman Jérôme Galon Franck Pagès Florent Petitprez Guido Kroemer Laurence Zitvogel Marie‐Caroline Dieu‐Nosjean Nicolás A. Giraldo
Topics: Cancer Immunotherapy and Biomarkers (86 papers)Monoclonal and Polyclonal Antibodies Research (68 papers)Immunotherapy and Immune Responses (60 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Nature Science Journal of Biological Chemistry
Partner nations: France United States Belgium

In The Last Decade

Catherine Sautès‐Fridman

247 papers receiving 27.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The immune contexture in human tumours: impact on clinical outcome

2012 3.5k citations Wolf H. Fridman, Franck Pagès et al. profile →
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

2016 2.2k citations Étienne Becht, Nicolás A. Giraldo et al. profile →
The immune contexture in cancer prognosis and treatment

2017 1.6k citations Wolf H. Fridman, Laurence Zitvogel et al. profile →
Tertiary lymphoid structures in the era of cancer immunotherapy

2019 1.1k citations Catherine Sautès‐Fridman, Florent Petitprez et al. profile →
Immune infiltration in human tumors: a prognostic factor that should not be ignored

2009 805 citations Franck Pagès, Jérôme Galon et al. profile →
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

2014 598 citations Claire Germain, Samantha Knockaert et al. profile →
Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells

2013 500 citations Jérémy Goc, Claire Germain et al. Cancer Research profile →
The clinical role of the TME in solid cancer

2018 487 citations Nicolás A. Giraldo, Yann Vano et al. profile →
Tertiary lymphoid structures in cancer and beyond

2014 432 citations Marie‐Caroline Dieu‐Nosjean, Jérémy Goc et al. profile →
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

2020 401 citations Florent Petitprez, Aurélien de Reyniès et al. profile →
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

2016 397 citations Étienne Becht, Aurélien de Reyniès et al. Clinical Cancer Research profile →
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

2022 379 citations Wolf H. Fridman, Florent Petitprez et al. profile →
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

2015 356 citations Nicolás A. Giraldo, Étienne Becht et al. Clinical Cancer Research profile →
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

2018 315 citations Florent Petitprez, Étienne Becht et al. profile →
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle

2023 137 citations Wolf H. Fridman, Catherine Sautès‐Fridman et al. profile →

Peers

Countries citing papers authored by Catherine Sautès‐Fridman

Since Specialization

Citations

This map shows the geographic impact of Catherine Sautès‐Fridman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sautès‐Fridman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sautès‐Fridman more than expected).

Fields of papers citing papers by Catherine Sautès‐Fridman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Sautès‐Fridman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sautès‐Fridman. The network helps show where Catherine Sautès‐Fridman may publish in the future.

Co-authorship network of co-authors of Catherine Sautès‐Fridman

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Sautès‐Fridman. A scholar is included among the top collaborators of Catherine Sautès‐Fridman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Sautès‐Fridman. Catherine Sautès‐Fridman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2687MO CONgRAtS: A randomized phase II study of nivolumab±relatlimab in patients with TLS-positive soft-tissue sarcomas 2025 ·Annals of Oncology ·Florent Peyraud,(unknown),(unknown),Jean‐Philippe Guégan,Jean‐Yves Blay,Emmanuelle Bompas,Mariella Spalato Ceruso,Wolf H. Fridman,Catherine Sautès‐Fridman,(unknown),(unknown),(unknown),(unknown)	0
2	Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 2023 ·Nature Communications ·Teresa Noviello,Anna Maria Di Giacomo,Francesca Pia Caruso,Alessia Covre,Roberta Mortarini,Giovanni Scala,(unknown),Sandra Coral,Wolf H. Fridman,Catherine Sautès‐Fridman,Silvia Brich,Giancarlo Pruneri,(unknown),(unknown),(unknown),Davide Bedognetti,Andrea Anichini,Michele Maio,Michele Ceccarelli	18
3	Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study 2019 ·European Journal of Cancer ·Axel Le Cesne,Perrine Marec‐Bérard,Jean‐Yves Blay,Nathalie Gaspar,François Bertucci,Nicolas Penel,Emmanuelle Bompas,Sophie Cousin,Maud Toulmonde,Alban Bessede,Wolf H. Fridman,Catherine Sautès‐Fridman,Michèle Kind,François Le Loarer,M. Pulido,Antoîne Italiano	114
4	Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death 2019 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Lenka Kašíková,Iva Truxová,Isabelle Cremer,Catherine Sautès‐Fridman,Oliver Kepp,Guido Kroemer,Radek Špíšek,Jitka Fučíková	3
5	Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma 2017 ·Clinical Cancer Research ·Nicolás A. Giraldo,Étienne Becht,Yann Vano,Florent Petitprez,Laetitia Lacroix,Pierre Validire,Rafael Sanchez‐Salas,Alexandre Ingels,Stéphane Oudard,Audrey Moatti,Bénédicte Buttard,Sarah Bourass,Claire Germain,Xavier Cathelineau,Wolf H. Fridman,Catherine Sautès‐Fridman	263
6	Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapybreakdown → 2016 ·Clinical Cancer Research ·Étienne Becht,Aurélien de Reyniès,Nicolás A. Giraldo,Camilla Pilati,Bénédicte Buttard,Laetitia Lacroix,Janick Sèlves,Catherine Sautès‐Fridman,Pierre Laurent‐Puig,Wolf H. Fridman	397
7	Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting 2015 ·Clinical Cancer Research ·Benoit Beuselinck,Sylvie Job,Étienne Becht,Alexandra Karadimou,Virginie Verkarre,Gabrielle Couchy,Nicolás A. Giraldo,Nathalie Rioux‐Leclercq,Vincent Molinié,Mathilde Sibony,Réza Elaidi,(unknown),Jean‐Jacques Patard,Arnaud Méjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Aurélien de Reyniès,Stéphane Oudard,Jessica Zucman‐Rossi	230
8	Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancerbreakdown → 2015 ·Clinical Cancer Research ·Nicolás A. Giraldo,Étienne Becht,Franck Pagès,Georgios Skliris,Virginie Verkarre,Yann Vano,Arnaud Méjean,Nicolas Saint-Aubert,Laetitia Lacroix,Ivo Natario,Audrey Lupo,Marco Alifano,Diane Damotte,Aurélie Cazes,Frédéric Triebel,Gordon J. Freeman,Marie‐Caroline Dieu‐Nosjean,Stéphane Oudard,Wolf H. Fridman,Catherine Sautès‐Fridman	356
9	Trial watch: Naked and vectored DNA-based anticancer vaccines 2015 ·OncoImmunology ·Norma Bloy,Aitziber Buqué,Fernando Aranda,Francesca Castoldi,Alexander Eggermont,Isabelle Cremer,Catherine Sautès‐Fridman,Jitka Fučíková,Jérôme Galon,Radek Špíšek,Éric Tartour,Laurence Zitvogel,Guido Kroemer,Lorenzo Galluzzi	32
10	TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer 2014 ·Cancer Research ·(unknown),Lucile Crozet,Diane Damotte,Kristina Iribarren,Catherine Schramm,Marco Alifano,Audrey Lupo,Julien Cherfils‐Vicini,Jérémy Goc,Sandrine Katsahian,(unknown),Marie‐Caroline Dieu‐Nosjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	88
11	Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cellsbreakdown → 2013 ·Cancer Research ·Jérémy Goc,Claire Germain,Thi Kim Duy Vo-Bourgais,Audrey Lupo,Christophe Klein,Samantha Knockaert,Luc de Chaisemartin,Hanane Ouakrim,Étienne Becht,Marco Alifano,Pierre Validire,Romain Remark,Scott A. Hammond,Isabelle Cremer,Diane Damotte,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	500
12	Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin 2013 ·Clinical Cancer Research ·Romain Remark,Marco Alifano,Isabelle Cremer,Audrey Lupo,Marie‐Caroline Dieu‐Nosjean,Marc Riquet,Lucile Crozet,Hanane Ouakrim,Jérémy Goc,Aurélie Cazes,Jean–François Fléjou,Laure Gibault,Virginie Verkarre,Jean‐François Régnard,(unknown),Stéphane Oudard,Bernhard Mlecnik,Catherine Sautès‐Fridman,Wolf H. Fridman,Diane Damotte	284
13	Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis 2013 ·PLoS ONE ·Sylvain Fisson,Hanane Ouakrim,Valérie Touitou,Sylvie Baudet,(unknown),Sabrina Donnou,(unknown),C Galand,Bahram Bodaghi,Phuc LeHoang,(unknown),Magali Le Garff‐Tavernier,Wolf H. Fridman,Catherine Sautès‐Fridman,Nathalie Cassoux,Hélène Merle‐Béral	57
14	Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer 2011 ·Cancer Research ·Luc de Chaisemartin,Jérémy Goc,Diane Damotte,Pierre Validire,Pierre Magdeleinat,Marco Alifano,Isabelle Cremer,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	252
15	Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma 2011 ·Cancer Research ·(unknown),Julien Cherfils‐Vicini,Diane Damotte,Lucile Crozet,Vincent Vieillard,Pierre Validire,Pascale André,Marie‐Caroline Dieu‐Nosjean,Marco Alifano,Jean‐François Régnard,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	381
16	The European Congress of Immunology: An international success thanks to its cooperative structure 2010 ·European Journal of Immunology ·Catherine Sautès‐Fridman,Brigitte Autran,Marc Girard,Claude Leclerc,Sylvie van der Werf	3
17	Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity 2010 ·Dermatology Research and Practice ·Joël F.G. Cohen-Solal,Lydie Cassard,Emilie Fournier,(unknown),Wolf H. Fridman,Catherine Sautès‐Fridman	18
18	Isolation and characterization of anti-Fc RIII (CD16) llama single-domain antibodies that activate natural killer cells 2007 ·Protein Engineering Design and Selection ·Ghislaine Béhar,Sophie Sibéril,(unknown),Patrick Chames,Martine Pugnière,Charlotte Boix,Catherine Sautès‐Fridman,Jean‐Luc Teillaud,Daniel Baty	72
19	Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells 2002 ·Journal of Clinical Investigation ·Lydie Cassard,Joël F.G. Cohen-Solal,Annie Galinha,Xavier Sastre‐Garau,Claire Mathiot,Jérôme Galon,Thierry Dorval,Alain Bernheim,Wolf H. Fridman,Catherine Sautès‐Fridman	25
20	A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays 1997 ·Hybridoma ·Frédéric Vely,Nadège Gruel,Janine Moncuit,Olivier Cochet‐Escartin,Hélène Rouard,(unknown),Jérôme Galon,Catherine Sautès‐Fridman,Wolf H. Fridman,Jean‐Luc Teillaud	35

About Catherine Sautès‐Fridman

Catherine Sautès‐Fridman is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 251 papers that have together received 27.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (86 papers), Monoclonal and Polyclonal Antibodies Research (68 papers) and Immunotherapy and Immune Responses (60 papers). The work is most often cited by research in Immunology (15.3k citations), Oncology (14.6k citations) and Cancer Research (3.7k citations). Catherine Sautès‐Fridman has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Wolf H. Fridman, Jérôme Galon, Franck Pagès, Florent Petitprez, Guido Kroemer, Laurence Zitvogel, Marie‐Caroline Dieu‐Nosjean, Nicolás A. Giraldo, Étienne Becht and Éric Tartour. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact